DMEPOS Prior Authorization Rule Aims To Tackle Fraud, Unnecessary Use
This article was originally published in The Gray Sheet
Executive Summary
A new CMS rule establishes a process for requiring prior authorization for durable medical equipment, prosthetics, orthotics and supplies to tackle fraud and unnecessary use of such products.
You may also be interested in...
CMS Will Require Prior Authorization For 31 Power Wheelchair Types
The US Medicare agency announced will require prior authorization for 31 types of power wheelchairs in an update to its list of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) that need prior authorization as a condition of payment under Medicare.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.